These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7438370)

  • 21. Comparison of the effects of intravenous and oral betaxolol on antegrade and retrograde conduction in patients with atrioventricular nodal reentrant and atrioventricular reentrant tachycardia.
    Kühlkamp V; Ickrath O; Haasis R; Seipel L
    Eur Heart J; 1989 Jun; 10(6):493-501. PubMed ID: 2569398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
    Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of intravenous isoproterenol in the electrophysiologic induction of atrioventricular node reentrant tachycardia in patients with dual atrioventricular node pathways.
    Huycke EC; Lai WT; Nguyen NX; Keung EC; Sung RJ
    Am J Cardiol; 1989 Nov; 64(18):1131-7. PubMed ID: 2479251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS; Lal R; Ruffy R
    Am J Cardiol; 1986 Jul; 58(1):80-5. PubMed ID: 3728336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms and management of paroxysmal supraventricular tachycardia.
    Kadish A; Passman R
    Cardiol Rev; 1999; 7(5):254-64. PubMed ID: 11208235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Termination of paroxysmal supraventricular tachycardia with a single oral dose of diltiazem and propranolol.
    Yeh SJ; Lin FC; Chou YY; Hung JS; Wu D
    Circulation; 1985 Jan; 71(1):104-9. PubMed ID: 3964710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults.
    Musto B; Cavallaro C; Musto A; D'Onofrio A; Belli A; De Vincentis L
    Am Heart J; 1992 Jul; 124(1):110-5. PubMed ID: 1615792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complete abolition of the reentrant supraventricular tachycardia zone using a new modality of cardiac pacing with simultaneous atrioventricular stimulation.
    Sung RJ; Styperek JL; Castellanos A
    Am J Cardiol; 1980 Jan; 45(1):72-8. PubMed ID: 7350776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous adenosine triphosphate disodium: its efficacy and electrophysiologic effects on patients with paroxysmal supraventricular tachycardias.
    Tajima T; Muramatsu T; Kanaka S; Yanagishita Y; Ide M; Dohi Y
    Pacing Clin Electrophysiol; 1986 May; 9(3):401-10. PubMed ID: 2423982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B; D'Onofrio A; Cavallaro C; Musto A; Della Gatta O; Marsico F
    G Ital Cardiol; 1987 May; 17(5):444-9. PubMed ID: 3115857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological diagnosis of participation of accessory pathway in patients with paroxysmal supraventricular tachycardia.
    Ito M; Shinoda S; Nagashima M; Chimori K; Kinoshita Y; Suzuki H
    Jpn Circ J; 1981 Apr; 45(4):472-82. PubMed ID: 7218501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrophysiological mechanisms and determinants of vagal maneuvers for termination of paroxysmal supraventricular tachycardia.
    Wen ZC; Chen SA; Tai CT; Chiang CE; Chiou CW; Chang MS
    Circulation; 1998 Dec; 98(24):2716-23. PubMed ID: 9851958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of propranolol on induction of A-V nodal reentrant paroxysmal tachycardia.
    Wu D; Denes P; Dhingra R; Khan A; Rosen KM
    Circulation; 1974 Oct; 50(4):665-77. PubMed ID: 4419586
    [No Abstract]   [Full Text] [Related]  

  • 34. Electrophysiologic effects of intravenous adenosine triphosphate disodium on the paroxysmal supraventricular tachycardias.
    Tajima T; Muramatsu T; Kanaka S; Yanagishita Y; Ide M; Dohi Y
    Jpn Heart J; 1985 Jan; 26(1):33-43. PubMed ID: 4009958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prophylaxis of AV nodal re-entry tachycardia.
    Tonkin AM; Shorne L
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():135-43. PubMed ID: 6956473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrioventricular nodal reentrant paroxysmal supraventricular tachycardia.
    Littmann L; Tenczer J; Fenyvesi T
    Arch Intern Med; 1984 Jan; 144(1):129-31. PubMed ID: 6691748
    [No Abstract]   [Full Text] [Related]  

  • 37. Reentry within the atrioventricular node: surgical cure with preservation of atrioventricular conduction.
    Pritchett EL; Anderson RW; Benditt DG; Kasell J; Harrison L; Wallace AG; Sealy WC; Gallagher JJ
    Circulation; 1979 Aug; 60(2):440-6. PubMed ID: 445760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of digitalis in patients with paroxysmal atrioventricular nodal tachycardia.
    Wellens HJ; Düren DR; Liem DL; Lie KI
    Circulation; 1975 Nov; 52(5):779-88. PubMed ID: 1236777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metoprolol in the treatment and prophylaxis of paroxysmal reentrant supraventricular tachycardia.
    Gmeiner R; Ng CK
    J Cardiovasc Pharmacol; 1982; 4(1):5-13. PubMed ID: 6176799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrophysiologic effects of ouabain in patients with preexcitation and circus movement tachycardia.
    Dhingra RC; Palileo EV; Strasberg B; Swiryn S; Bauernfeind R; Wyndham C; Rosen KM
    Am J Cardiol; 1981 Jan; 47(1):139-44. PubMed ID: 7457399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.